LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The
Despite significant challenges, the U.S. economy has showcased remarkable resilience. Fears of an imminent recession have been allayed by two consecutive quarters of robust GDP growth exceeding 3%.
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
CONMED's (CNMD) adjusted fourth-quarter earnings misses while sales beat estimates on the back of strong growth in the United States and international markets. Gross margin improves with a rise in sal
CONMED Corporation (CNMD) Q4 2023 Earnings Call Transcript
While the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare
Conmed (CNMD) came out with quarterly earnings of $1.06 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.42 per share a year ago.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Highlights Sales of $3

Med-tech stock Conmed dips ahead of big Q4 report

07:34am, Wednesday, 31'st Jan 2024
When Utica, NY-based medical technology company CONMED Corporation NYSE: CNMD reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in years.
Besides Wall Street's top -and-bottom-line estimates for Conmed (CNMD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2023 after the market close on Wednesday, January 31, 2024. T
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Presi
CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE